Community Healthcare Trust (CHCT)
(Delayed Data from NYSE)
$17.99 USD
-0.96 (-5.07%)
Updated Aug 9, 2024 04:00 PM ET
After-Market: $17.98 -0.01 (-0.06%) 7:58 PM ET
4-Sell of 5 4
B Value D Growth A Momentum B VGM
Community Healthcare Trust (CHCT) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$25.67 | $30.00 | $21.00 | 35.46% |
Price Target
Based on short-term price targets offered by six analysts, the average price target for Community Healthcare Trust comes to $25.67. The forecasts range from a low of $21.00 to a high of $30.00. The average price target represents an increase of 35.46% from the last closing price of $18.95.
Analyst Price Targets (6 )
Broker Rating
Community Healthcare Trust currently has an average brokerage recommendation (ABR) of 2.50 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by six brokerage firms. The current ABR compares to an ABR of 2.17 a month ago based on six recommendations.
Of the six recommendations deriving the current ABR, two are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 33.33% and 16.67% of all recommendations. A month ago, Strong Buy made up 33.33%, while Buy represented 16.67%.
Broker Rating Breakdown
![Broker Rating Visualization](https://widget3.zacks.com/images/charts/bar/brokerage/bar/CHCT.png)
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 2 | 2 |
Buy | 1 | 1 | 1 | 1 | 1 |
Hold | 2 | 2 | 3 | 3 | 3 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 1 | 1 | 0 | 0 | 0 |
ABR | 2.50 | 2.50 | 2.17 | 2.17 | 2.17 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
7/31/2024 | Robert W. Baird & Co. | Wesley Golladay | Hold | Hold |
7/31/2024 | Piper Sandler | Alexander Goldfarb | Hold | Hold |
7/31/2024 | Evercore Partners | James Kammert | Not Available | Strong Sell |
7/30/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
5/9/2024 | Colliers Securities | Barry Oxford | Moderate Buy | Moderate Buy |
5/1/2024 | Truist Securities | Michael Lewis | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.50 |
ABR (Last week) | 2.50 |
# of Recs in ABR | 6 |
Average Target Price | $25.67 |
LT Growth Rate | 8.00% |
Industry | REIT and Equity Trust - Other |
Industry Rank by ABR | 80 of 253 |
Current Quarter EPS Est: | 0.60 |